Day: March 16, 2015

CVS Health President and CEO Larry J. Merlo gives an interview on the floor of the New York Stock Exchange September 3, 2014. Credit: Reuters/Brendan McDermid (Reuters) – The entry of copycat biotech drugs (Biosimilars) into the U.S. market could… Continue Reading →

Advances in technology are rapidly improving the range of available biotechnological tools and applications. Interfacial opportunities, such as those combining biomedical improvements with aspects of engineering, computing and innovative biomaterials are at the forefront of these enhancements. Personalised and predictive… Continue Reading →